Mordor Intelligence has published a new report on the Pharmaceutical Contract Manufacturing Organization (CMO) Market, offering a comprehensive analysis of trends, growth drivers, and future ...

Market valued at $16.86B in 2024, projected 4.20% CAGR growth driven by VOC regulation compliance, bio-based adoption, ...

Identiv, Inc. , a global leader in RFID- and BLE-enabled Internet of Things (IoT) solutions, announced today that the Tag-N-Trac and Identiv Cold Chain Tracking Solution has received a 2025 IoT ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

Halo Pharma, a CDMO, will become a stand-alone business as a result of the sale of the Noramco API and associated businesses ...

Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are ...

Siegfried, a global CDMO for the pharmaceutical industry, has signed binding agreements with an affiliate of SK Capital ...

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland)The ...

Patient-centric design, sustainability, and the GLP-1 boom dominate presentations as well as panel discussions.

The market is ripe for growth driven by pharma outsourcing to CDMOs, emphasizing advanced drug products and integrated ...

PMMI research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome ...

ST Pharm has struck a deal with an undisclosed U.S.-based biotech to produce active pharmaceutical ingredients (APIs) for an ...